Acasă › Limfom Burkitt › Pennsylvania › Philadelphia
Studii clinice pentru Limfom Burkitt în Philadelphia, PA
16 studii pentru Limfom Burkitt caută participanți în și în jurul orașului Philadelphia (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
În curs de recrutareFaza 3
- Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
În curs de recrutareFaza 1
- Children's Hospital of Philadelphia, Philadelphia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
În curs de recrutareFaza 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · La 25 mi distanță
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
În curs de recrutareFaza 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Blinatumomab Consolidation in Real World
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- University of Pennsylvania, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
În curs de recrutareStudiu observațional
- Children's Hospital of Philadelphia, Philadelphia
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
În curs de recrutareFaza 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · La 25 mi distanță
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
În curs de recrutareFaza 1/2
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
În curs de recrutareFaza 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · La 25 mi distanță
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
În curs de recrutareFaza 3
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · La 25 mi distanță
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
În curs de recrutareFaza 2
- Children's Hospital of Philadelphia, Philadelphia
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
În curs de recrutare
- Children's Hospital of Philadelphia, Philadelphia
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
În curs de recrutareFaza 1/2
- Children's Hospital of Philadelphia, Philadelphia
Co-administration of CART22-65s and huCART19 for B-ALL
În curs de recrutareFaza 1/2
- Children's Hospital of Philadelphia, Philadelphia
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
În curs de recrutareFaza 1/2
- Children's Hospital of Philadelphia, Philadelphia
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
În curs de recrutareFaza 2
- Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · La 25 mi distanță
Studii pentru Limfom Burkitt în alte orașe
- Houston, TX21 studii
- Milwaukee, WI16 studii
- Chicago, IL15 studii
- Cincinnati, OH13 studii
- New York City, NY13 studii
- Atlanta, GA12 studii
- Aurora, CO11 studii
- Seattle, WA11 studii
- Durham, NC10 studii
- Boston, MA10 studii
- Kansas City, MO10 studii
- Los Angeles, CA10 studii
Alte studii în Philadelphia
- Cancer (toate tipurile)59 studii
- Cancer de sân56 studii
- Cancer pulmonar cu celule non-pătrate51 studii
- Cancer metastatic46 studii
- Cancer de prostată44 studii
- Cancer colorectal44 studii
- Cancer ovarian44 studii
- Cancer pulmonar36 studii
- Leucemie mieloasă acută34 studii
- Insuficiență cardiacă31 studii
- Cancer endometrial28 studii
- Depresie26 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.